Issue 2, 2022

D–A systems based on oxazolone–coumarin triazoles as solid-state emitters and inhibitors of human cervical cancer cells (HeLa)

Abstract

A collection of solid-state emitters based on oxazolone–coumarin triazoles with the potential to induce apoptosis in the human cervical cancer cell line HeLa is reported. These new classes of fluorescent inhibitors were synthesized by the sequential use of multicomponent reactions (MCR) and click chemistry with oxazolone alkynes and coumarin azides and the origin of their solid state emission properties were related to an unconventional AIE process. The significantly high first-order hyperpolarizability values (36–118 times higher than the standard molecule urea) obtained from the DFT calculations showed that the emission from these molecules follows nonlinear optical characteristics. The molecules also showed excellent binding affinity towards CDK2 with high docking scores and the binding sites obtained from docking studies are in good agreement with the reactivity sites determined from the DFT-based molecular electrostatic potential (MEP) analysis. Cytotoxicity studies of the selected molecules showed the potential of these molecules as inhibitors of human cervical cancer cells (HeLa). Overall, the optical and biological properties of these new solid-state emitters are promising for a broad spectrum of applications in medicinal and materials chemistry.

Graphical abstract: D–A systems based on oxazolone–coumarin triazoles as solid-state emitters and inhibitors of human cervical cancer cells (HeLa)

Supplementary files

Article information

Article type
Paper
Submitted
30 Aug 2021
Accepted
20 Nov 2021
First published
22 Nov 2021

New J. Chem., 2022,46, 480-489

D–A systems based on oxazolone–coumarin triazoles as solid-state emitters and inhibitors of human cervical cancer cells (HeLa)

A. Shamsiya and D. Bahulayan, New J. Chem., 2022, 46, 480 DOI: 10.1039/D1NJ04151G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements